Bank of Zhengzhou Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

Bank of Zhengzhou şirketinin toplam varlıkları CN¥666.6B ve toplam özkaynağı CN¥56.8B dır. Toplam mevduat CN¥416.2B ve toplam krediler CN¥404.1B dır. 2.1% Net Faiz Marjı kazanır. Şu anda toplam kredilerin 1.7% i olan kötü krediler için yeterli ödeneği vardır. Nakit ve kısa vadeli yatırımlar CN¥83.4B dir.

Anahtar bilgiler

11.7x

Varlık/özkaynak oranı

2.1%

Net faiz marjı

Toplam mevduat	CN¥416.20b
Kredi/mevduat oranı	Uygun
Batık krediler	1.7%
Sorunlu krediler için ayrılan karşılık	Yeterli
Cari oran	Düşük
Nakit ve eşdeğerleri	CN¥83.40b

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

We Think Shareholders May Want To Consider A Review Of Bank of Zhengzhou Co., Ltd.'s (HKG:6196) CEO Compensation Package

Jun 11

Here's What You Should Know About Bank of Zhengzhou Co., Ltd.'s (HKG:6196) 4.8% Dividend Yield

Mar 24

Are Insiders Buying Bank of Zhengzhou Co., Ltd. (HKG:6196) Stock?

Feb 26

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Finansal Kurumlar Analizi

Varlık Seviyesi: 6196 'nin Varlıkların Öz Sermayeye Oranı ( 11.7 x) orta'dır.

Kötü Krediler İçin Ödenek: 6196 yeterli kötü krediler için bir ödeneği var ( 166 %).

Düşük Riskli Yükümlülükler: 6196 'un yükümlülüklerinin 68% 'i esas olarak düşük riskli finansman kaynaklarından oluşmaktadır.

Kredi Seviyesi: 6196 Kredi/Varlık oranı açısından uygun bir seviyeye sahiptir ( 61% ).

Düşük Riskli Mevduatlar: 6196 'nin Kredi/Mevduat oranı ( 97% ) uygundur.

Kötü Kredilerin Seviyesi: 6196 uygun düzeyde kötü krediler içeriyor ( 1.7 %).

Bank of Zhengzhou Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Recent updates

Third quarter 2024 earnings released

Bank of Zhengzhou Co., Ltd. Announces Board Resignations

Now 24% undervalued

Investor sentiment improves as stock rises 30%

Bank of Zhengzhou Co., Ltd. to Report Q3, 2024 Results on Oct 31, 2024

Second quarter 2024 earnings released: EPS: CN¥0.078 (vs CN¥0.088 in 2Q 2023)

Bank of Zhengzhou Co., Ltd. to Report First Half, 2024 Results on Aug 30, 2024

Bank of Zhengzhou Co., Ltd., Annual General Meeting, Jun 27, 2024

New minor risk - Profit margin trend

First quarter 2024 earnings released: EPS: CN¥0.11 (vs CN¥0.12 in 1Q 2023)

Bank of Zhengzhou Co., Ltd. to Report Q1, 2024 Results on Apr 30, 2024

Full year 2023 earnings released

Bank of Zhengzhou Co., Ltd. to Report Fiscal Year 2023 Results on Mar 30, 2024

Third quarter 2023 earnings released: EPS: CN¥0.08 (vs CN¥0.091 in 3Q 2022)

Bank of Zhengzhou Co., Ltd. Announces Board Changes

Second quarter 2023 earnings released: EPS: CN¥0.11 (vs CN¥0.14 in 2Q 2022)

Bank of Zhengzhou Co., Ltd. Announces Executive Changes

Insider recently sold HK$2.7m worth of stock

Full year 2022 earnings released: EPS: CN¥0.17 (vs CN¥0.33 in FY 2021)

Insider recently sold HK$2.3m worth of stock

Insider recently sold HK$13m worth of stock

Insider recently sold HK$3.1m worth of stock

Insider recently sold HK$2.4m worth of stock

Insider recently sold HK$1.9m worth of stock

Insider recently sold HK$5.2m worth of stock

Bank of Zhengzhou Co., Ltd. Appoints Mr. ZHAO Fei as the President

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: CN¥0.11 (vs CN¥0.099 in 3Q 2021)

Bank of Zhengzhou Co., Ltd. Announces Board Changes

Bank of Zhengzhou Co., Ltd. to Report Q3, 2022 Results on Oct 28, 2022

Bank of Zhengzhou Co., Ltd. Announces Resignation of Mr. Shen Xueqing as President

Second quarter 2022 earnings released: EPS: CN¥0.17 (vs CN¥0.15 in 2Q 2021)

Bank of Zhengzhou Co., Ltd. to Report First Half, 2022 Results on Aug 30, 2022

First quarter 2022 earnings released: EPS: CN¥0.14 (vs CN¥0.14 in 1Q 2021)

Less than half of directors are independent

Bank of Zhengzhou Co., Ltd. to Report Q1, 2022 Results on Apr 28, 2022

Full year 2021 earnings released: EPS: CN¥0.33 (vs CN¥0.34 in FY 2020)

Bank of Zhengzhou Co., Ltd. Announces Board Changes

Bank of Zhengzhou Co., Ltd. Appoints Song Ke as Chairperson of the Related Party Transactions Control Committee

Bank of Zhengzhou Co., Ltd. Announces Board Changes

Insider recently sold HK$145m worth of stock

Third quarter 2021 earnings released

Insider recently bought HK$151m worth of stock

Insider recently bought HK$146m worth of stock

VP, Joint Company Secretary, Director of the Office of the BOD & Board Secretary Chunqiao Fu has left the company

Second quarter 2021 earnings released: EPS CN¥0.18 (vs CN¥0.21 in 2Q 2020)

Non-Executive Director Jingguo Zhang has left the company

Independent Non-Executive Director Taifeng Xie has left the company

Non-Executive Director Yutao Fan has left the company

Non-Executive Director Songwei Liang has left the company

Independent Non-Executive Director Mei-Bo Chan has left the company

Independent Non-Executive Director Ge Wu has left the company

We Think Shareholders May Want To Consider A Review Of Bank of Zhengzhou Co., Ltd.'s (HKG:6196) CEO Compensation Package

Insider recently bought HK$57m worth of stock

First quarter 2021 earnings released

Insider recently bought HK$14m worth of stock

Full year 2020 earnings released: EPS CN¥0.41 (vs CN¥0.43 in FY 2019)

Here's What You Should Know About Bank of Zhengzhou Co., Ltd.'s (HKG:6196) 4.8% Dividend Yield

Bank of Zhengzhou Co., Ltd. to Report Fiscal Year 2020 Results on Mar 30, 2021

Are Insiders Buying Bank of Zhengzhou Co., Ltd. (HKG:6196) Stock?

Bank of Zhengzhou Co., Ltd. to Report Fiscal Year 2020 Results on Mar 31, 2021

New 90-day high: HK$2.10

New 90-day high: HK$1.98

Bank of Zhengzhou Co., Ltd. announced that it has received CNY 4.64 billion in funding from Henan Guoyuan Trade Co., Ltd., Bridge Trust Co., Ltd, Zhengzhou Investment Holdings Co., Ltd.

Bank of Zhengzhou Co., Ltd. to Report Q3, 2020 Results on Oct 29, 2020

Bank of Zhengzhou Co., Ltd. Approves Changes in Accounting Policies of the Company

Bank of Zhengzhou Co., Ltd. to Report First Half, 2020 Results on Aug 31, 2020

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Finansal Kurumlar Analizi

Sağlıklı şirketleri keşfedin